–{•¶‚ÖƒXƒLƒbƒv

ƒXƒ^ƒbƒtSTAFF


y‹³Žö@–î–ì@ˆçŽq@(Ikuko Yano, Ph.D.)

@og
@•ºŒÉŒ§

@Š‘®Šw‰ï
@American Society for Clinical Pharmacology and Therapeutics
@International Association of Therapeutic Drug Monitoring and Clinical Toxicology
@“ú–{–òŠw‰ï
@“ú–{ˆã—ÖòŠw‰ïi‘ã‹cˆõEŠw‰ï”F’èŽw“±–òÜŽtj
@“ú–{—Տ°–ò—Šw‰ïiŽÐˆõEŠw‰ï”F’èŽw“±–òÜŽtj
@“ú–{TDMŠw‰ïi•]‹cˆõj
@“ú–{–ò•¨“®‘ÔŠw‰ïi•]‹cˆõj

“Á–½uŽt@’†ì@•×@iTsutomu Nakagawa, Ph.D.j

@og
@–kŠC“¹
@
@Š‘®Šw‰ï
@“ú–{–òŠw‰ï
@“ú–{¶‰»Šw‰ï


ƒXƒ^ƒbƒt

ŽR–{@˜aG
Š‘®Šw‰ï
International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT)
“ú–{–òŠw‰ï
“ú–{ˆã—ÖòŠw‰ïiŠw‰ï”F’èŽw“±–òÜŽtj
“ú–{TDMŠw‰ï
“ú–{t‘Ÿ•a–ò•¨—Ö@Šw‰ïiŠw‰ï”F’èê–å–òÜŽtj
“ú–{“§ÍˆãŠw‰ï
“ú–{ƒQƒmƒ€–ò—Šw‰ïi—Ž–j


Œ¤‹†ˆõ

Žµ—¢@”ŽÍ
_ŒË‘åŠw‘åŠw‰@ˆãŠwŒ¤‹†‰È@ˆãŠwŒ¤‹†ˆõ


‘åŠw‰@¶

ì“ˆ@_•½
_ŒË‘åŠw‘åŠw‰@ˆãŠwŒ¤‹†‰Èˆã‰ÈŠwêUiŽÐ‰ïl”ŽŽm‰Û’öj
‹g“c@Ê‰Ä
_ŒË‘åŠw‘åŠw‰@ˆãŠwŒ¤‹†‰ÈƒoƒCƒIƒƒfƒBƒJƒ‹ƒTƒCƒGƒ“ƒXêUi•a—f’f•”j

Šw•”¶

‹à’J@˜aÆ
_ŒË‘åŠwˆãŠw•”
ˆªŒ´@—T“Þ
_ŒË–ò‰È‘åŠw@–òŠw—Տ°‹³ˆçƒZƒ“ƒ^[
¬–ì@‚ЂƂÝ
_ŒË–ò‰È‘åŠw@–òŠw—Տ°‹³ˆçƒZƒ“ƒ^[
ŠâŠÔ@‹|“Þ
_ŒË–ò‰È‘åŠw@–òŠw—Տ°‹³ˆçƒZƒ“ƒ^[
‘ºì@ˆŸŒõ
_ŒË–ò‰È‘åŠw@–òŠw—Տ°‹³ˆçƒZƒ“ƒ^[



ƒoƒi[ƒXƒy[ƒX

–ò•¨“®‘ÔŠwE–òÜŠw•ª–ì

§650-0017
•ºŒÉŒ§_ŒËŽs’†‰›‹æ“í’¬7’š–Ú5-2
_ŒË‘åŠwˆãŠw•”•‘®•a‰@@–òÜ•”

TEL: 078-382-6659
FAX: 078-382-6702
E-mail: yakuken@med.kobe-u.ac.jp